arrow
C

Chang-Sup Lim

surgery
H指数:17
被引数:1,050

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of neoadjuvant FOLFIRINOX in resectable pancreatic cancer (NeoFOL-R): study protocol for an international, multicenter, prospective, randomized controlled trial

新辅助FOLFIRINOX在可切除胰腺癌中的疗效(NeoFOL-R):一项国际、多中心、前瞻性、随机对照试验的研究方案

2026-02-240
OAAI
Changing Clinical Meaning of Resection Margin Status According to the Treatment Paradigm and the Potential Role of Perioperative Radiotherapy for Patients with Pancreatic Ductal Adenocarcinoma: An Updated Multicenter Retrospective Cohort Study

根据治疗范式的变化,胰腺导管腺癌患者切除边缘状态的临床意义转变以及围手术期放射治疗的潜在作用:一项更新的多中心回顾性队列研究

2025-04-300
OA
Hepatocyte TM4SF5-mediated cytosolic NCOA3 stabilization and macropinocytosis support albumin uptake and bioenergetics for hepatocellular carcinoma progression

肝细胞TM4SF5介导的细胞质NCOA3稳定化和巨胞饮作用支持白蛋白摄取及肝细胞癌进展所需的生物能量学

2025-04-040
OA
Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)
2021-11-156
OAAI
Clinical validation of scoring systems of postoperative pancreatic fistula after pancreatoduodenectomy: applicability to Eastern cohorts?

胰十二指肠切除术后胰瘘评分系统的临床验证: 适用于东部队列?

2019-06-0123
OAAI
Determination of Malignant and Invasive Predictors in Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Suggested Scoring Formula
2011-01-0133
OAAI